Commit Biologics to present data on its Bispecific Complement Engaging (BiCE™) platform at the 16th International Conference on Complement Therapeutics Commit Biologics is pioneering a novel approach ...
"Apabetalone, a selective bromodomain extra-terminal (BET) protein inhibitor that significantly decreases abundance and activity of complement proteins" Resverlogix Corp. ("Resverlogix" or the ...
Complement inhibitors companies are AstraZeneca, Annexon, Inc., Dianthus Therapeutics, Alsonex Pharmaceuticals, Mallinckrodt, CANbridge Pharmaceuticals, Beijing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback